Case Report: Neuromyelitis Optica Associated With SARS-CoV-2
A first case report of NMO possible incited by SARS-CoV-2 infection.
Tzu-Ying Chuang, MD, PhD, and Dhanashri Miskin, MD
09.25.20Multiple Sclerosis Does Not Increase Risk of Contracting COVID-19, But Some Treatments, EDSS, and Progressive Status May Increase COVID-19 Severity
09.24.20Cannabis-Derived Nabiximols Well-Tolerated and Effective for Spasticity in Multiple Sclerosis
Trending Autoantibodies Causing Movement Disorders
As new autoantibodies are described, the field of autoimmune movement disorders is ever expanding.
F. Stephen Benesh, MD, and Shruti P. Agnihotri, MD
Immune-Mediated Cerebellar Ataxias
Cerebellar ataxia may be a prominent feature in autoimmune encephalitis and paraneoplastic syndromes.
Fabio Fieni Toso, MD; Rene de Araújo Gleizer, MD; and Lívia Almeida Dutra, MD, PhD
Treatment consists of immunomodulatory therapies and symptom management.
Jakai D. Nolan, DO, MPH, and Jacqueline A. Nicholas, MD, MPH
Movement Disorders in Antiphospholipid Syndrome & Systemic Lupus Erythematosus
Several movement disorders are seen with APS and SLE, most commonly chorea.
Danielle S. Shpiner, MD; Crystal Dixon, MD; Melissa R. Ortega, MD; and Henry Moore, MD
Anti-N-Methyl D Aspartate Receptor Encephalitis
Encephalitis caused by antibodies to the N-methyl-D-aspartate receptor causes symptoms of movement disorders, seizure, and psychiatric disturbances.
Nidhiben Anadani, MD
Utility of Autoantibody Profiles
Algorithmic testing for autoantibody profiles is more sensitive than physician-selected single autoantibody testing.
Shailee S. Shah, MD, and Andrew McKeon, MD
Autoimmune Movement Disorders in Children
A clinical approach.
Monideep Dutt, MD; Jamika Hallman-Cooper, MD; Ekta Bery, MD; Mohammed Shahnawaz, MD; and Grace Gombolay, MD
Autoimmune Movement Disorders in Adults
As antibodies to neuronal targets are described, we see the clinical spectrum and pathophysiology of autoimmune movement disorders more clearly.
Bettina Balint, MD
Guest Medical Editor's Page
Autoimmune Movement Disorders
Autoimmune movement disorders remind us to learn from our history.
Jill M. Giordano Farmer, DO
09.15.20Diroximel Fumarate Treatment of Relapsing MS Has Improved Gastrointestinal Tolerability and Improved Quality of Life
09.15.20T-Cell Therapy Targeting Epstein-Barr Virus Provided Sustained Disability Improvement for Progressive MS in Phase 1a Clinical Trial
09.15.20Study Examining Ocrelizumab Treatment in African-Americans, Hispanic- and Latinx-Americans Is Actively Enrolling
08.24.20FDA Approves Ofatumumab—First and Only Self-administered B-cell Therapy for Relapsing MS
08.07.20Clinical Trials Begin for Combination of Interferon Beta-1A and Remdesivir
08.06.20Ofatumumab Reduced Annualized Relapse Rate in MS in Phase 3 Clinical Trials
08.05.20DHODH Inhibitor Reduces Lesions Significantly in Relapsing-Remitting MS